Biotech: Page 51
-
PharmaVoice Team/PharmaVoice
Letter from the Editor
Where do we go from here? There’s no getting away from it. It dominates the news. Everybody is talking about it. It, of course, is the economy. “Now, more than ever, in these economic times …" seems to be the theme of every news story (hard and soft), financial pundit, TV program, commercial, etc...
By Taren Grom • March 25, 2009 -
PharmaVoice Team/PharmaVoice
Improving Health Literacy
The statistics are staggering: As many as 90 millions Americans are functionally healthcare illiterate and low health literacy skills cost the U.S.health system about $73 billion.The industry is beginning to school itself in ways to address this national healthcare issue. BY TAREN GROM The health...
By PharmaVoice Team • March 17, 2009 -
Explore the Trendline➔
Getty Images
TrendlineOncology R&D
Cancer research remains a prime focus for the industry and often leads to pharma’s most impactful breakthroughs.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
Elaine Riddell: Measuring Up
LEADING A MULTIMILLION DOLLAR COMPANY AND ENSURING ITS SUCCESS TAKES SEVERAL KEY CHARACTER TRAITS. Clearly there is a need for vision, courage, and the intelligence to identify personal strengths and weaknesses. Add to this mix a passion for the job to inspire managers and staff. “I don’t know wh...
By PharmaVoice Team • March 17, 2009 -
PharmaVoice Team/PharmaVoice
Talent Pool
78 J a n u a r y / F e b r u a r y 20 0 2 PharmaVOICE to Dr. Lars Ekman, president of bio pharmaceutical R&D. Dr. Pilgrim received her M.D. and Ph.D. from Oxford University. Robert P. LUCIANO LongServing Executive Retires from ScheringPlough Board Chairman emeri tus and a director of Schering...
By PharmaVoice Team • March 11, 2009 -
PharmaVoice Team/PharmaVoice
What's New
Ventiv Health Inc., MDS Pharma Services,and Paul Capital Partners have joined forces to provide lifesci ences companies with a broad range of development, commercialization,and investment support. The alliance combines the drug discovery and development expertise of MDS Pharma Services,the commer...
By PharmaVoice Team • March 11, 2009 -
PharmaVoice Team/PharmaVoice
Defining GLOBAL
BY DENISE MYSHKO AND ROBIN ROBINSON KARLA ANDERSON Managing Director, Life Sciences BearingPoint Global is a perspective of looking at the business in its totality, not just at a given market or a given country or a given set of rules and regulations, but at the business as a whole. It’s always c...
By Denise Myshko and Robin Robinson • March 1, 2009 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharmaceutical POOL Deirdre CONNELLY GlaxoSmithKline Selects Head of North American Pharma Business Deirdre Connelly, former president of U.S. operations at Eli Lilly, has joined GlaxoSmithKline (GSK) as president, North American pharmaceuticals. Ms. Connelly was appointed president of U.S. opera...
By PharmaVoice Team • Feb. 26, 2009 -
PharmaVoice Team/PharmaVoice
What's New
New healthcare-related products, services, and companies GfK Consolidates Market Research Operations Operating as one entity allows GfK Healthcare to pull together its strengths and individual leadership positions across multi-client research. The GfK U.S. Healthcare Companies has consolidated it...
By PharmaVoice Team • Feb. 26, 2009 -
PharmaVoice Team/PharmaVoice
Talent Pool
TALENT POOL EXECUTIVE APPOINTMENTS AND PROMOTIONS IN THE HEALTHCARE INDUSTRY Pharma POOL Lamberto ANDREOTTI Dr. Andrew G. BODNAR Donald J. HAYDEN Dr. James B. D. PALMER Thomas J. PICKARD David L. ZABOR Bristol-Myers Squibb Announces New Senior Leadership Team — Appoints Former GlaxoSmithKline V...
By PharmaVoice Team • Feb. 23, 2009 -
PharmaVoice Team/PharmaVoice
Table of Contents
4 S e p t e m be r / O c t o b e r 2 00 1 PharmaVOICE The promise of things to come The Internet’s future potential is in its infinite ability to allow marketers to develop personalized messages 48 Conquering the market, one segment at a time Cytyc’s launch of the ThinPrep System is making an imp...
By PharmaVoice Team • Feb. 16, 2009 -
PharmaVoice Team/PharmaVoice
What's New
WHAT’S NEW NEW HEALTHCARERELATED PRODUCTS, SERVICES, AND COMPANIES The OmniLog ID Microbial Identification System, which includes proprietary software and sophisticat ed hardware, is designed to automate and simplify the process of characterizing and identifying a wide range of aerobic bacteria. ...
By PharmaVoice Team • Feb. 12, 2009 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Drug Delivery’s RISE CHALLENGES Big Pharma’s Dominance Set to soar from just $2.4 billion to about $12 billion in just five years, the value of drug delivery technologies and the market clout of developers are making established pharmaceutical giants sit up and take notice, according to a study r...
By PharmaVoice Team • Feb. 12, 2009 -
PharmaVoice Team/PharmaVoice
Table of Contents
6 J u l y / A u gu s t 20 01 PharmaVOICE CSOs: Not just hired guns Contract sales organizations have come a long way to stay a step ahead of their clients’ needs 34 Unleashing the power of Nexium AstraZeneca marketers are positioning the company’s new proton pump inhibitor to replace Prilosec, th...
By PharmaVoice Team • Feb. 11, 2009 -
PharmaVoice Team/PharmaVoice
Agency Pitches — In Need of an Umpire
BY Taren Grom THE STARTING LINEUP … RYANABBATE. President and managing director, Pacific Communications,Costa Mesa,Calif. ARTHUR ANDERSON.Managing principal, Morgan Anderson Consulting, NewYork SCOTT COTHERMAN. President and CEO,Corbett Healthcare Group,Chicago RODHANLON. Chairman,Wanamaker Assoc...
By PharmaVoice Team • Feb. 11, 2009 -
PharmaVoice Team/PharmaVoice
Between Two Coasts
VIEW on Biotech Hoping to transform the rust belt into the Biotech belt, Michael Rosen, is spearheading an initiative to make the Midwest a mecca for biotech activity. IN AN EXCLUSIVE INTERVIEW WITH PHARMAVOICE, MICHAEL ROSEN,PRESIDENT AND CEO OF ENDOREX CORP. AND CO-CHAIRMAN OF THE BOARD OF THE ...
By PharmaVoice Team • Feb. 11, 2009 -
PharmaVoice Team/PharmaVoice
A Piece of the Pie
Calling all marketers: don’t cancel those journal ads just yet, it may be time to evaluate the overall marketing mix for your brand’s promotion. Before brand managers and media directors make their next decision on how to divide up their promotional budget, they should consider the results of a c...
By PharmaVoice Team • Feb. 10, 2009 -
PharmaVoice Team/PharmaVoice
Talent Pool
Dr.. Hubertus ERLEN New Schering AG CEO named to replace Dr.Vita who retired Dr. Hubertus Erlen has assumed the chairmanship of the executive board of Scher ing AG, suc ceeding Dr. Giuseppe Vita, who retired after 12 years as chairman. Schering AG is a researchbased pharma ceutical company, focus...
By PharmaVoice Team • Feb. 10, 2009 -
PharmaVoice Team/PharmaVoice
What's New
“The Catalyst system allows an advertiser to pro vide customers with specific information that has been tailored to the answers they provide and is writ ten in a style they’re comfortable with,” says David Sadock,VP, marketing and sales, HealthAnswers Inc., Pennington, N.J. “Regardless of whether...
By PharmaVoice Team • Feb. 10, 2009 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
PUBLISHER Lisa Banket EDITOR Taren Grom CREATIVE DIRECTOR Marah Walsh CONTRIBUTING EDITORS Diane Hoffman Virginia Kirk Denise Myshko Lynda Sears Copyright 2001 by PharmaLinx LLC, Titusville, NJ Printed in the U.S.A. Volume One, Number One PharmaVoice is published six times per year by PharmaLinx ...
By Taren Grom • Feb. 10, 2009 -
PharmaVoice Team/PharmaVoice
Table of Contents
We invite you to explore the digital edition of PharmaVOICE magazine. The interactive format allows you to easily read, share with friends, and click on podcasts, videos, webinars, whitepapers, and Website links to access additional resources. Getting started with your digital edition is this eas...
By PharmaVoice Team • Jan. 28, 2009 -
PharmaVoice Team/PharmaVoice
From the Heart: Personal Stories, Public Causes
BY KIM RIBBINK The expression the acorn becomes an oak is never truer than in charitable and philanthropic acts. Individuals who are moved by a certain cause — as a result of their own experiences, beliefs, or outlooks — often inspire many others to rally to that cause. Last year,PharmaVOICE bega...
By PharmaVoice Team • Jan. 28, 2009 -
PharmaVoice Team/PharmaVoice
Last Word
We are honored to receive this prestigious Enterprise award from Eastern Technology Council, says Robert Broeze, Ph.D., President and CEO of Laureate Pharma. Dr. Broeze, who is with Dr. Michiel Ultee, VP of Process Sciences, in front of an Applikon 20L Bioreactor, says the award validates the com...
By PharmaVoice Team • Jan. 28, 2009 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma POOL William GARBARINI Jr. Ferring Promotes Head of Orthopedics and Urology Business Ferring Pharmaceuticals has promoted William Garbarini Jr. to VP of its orthopedics and urology business unit, recently formed by the merging of these clinical product areas. Mr. Garbarini was formerly exe...
By PharmaVoice Team • Jan. 28, 2009 -
PharmaVoice Team/PharmaVoice
E-Media
New Electronic and Web-based Applications, Sites, and Technologies Featured Briefs: Lathian Health Offers Closed-Loop Promotion Tool Informa Launches CRM/ROI Tracking Solution Verticals onDemand Offers Analytics and Reporting Solution OpenQ Unveils KOL Solutions Tibco Spotfire Solution Speeds Dru...
By PharmaVoice Team • Jan. 27, 2009 -
PharmaVoice Team/PharmaVoice
Partnering for Success
Mitigate risk by reading red flags Creating effective partnerships is more crucial than ever, so being able to spot red flags from a distance, and knowing how to deal with potential problems close up is of great value today. Careful planning, goal setting, and communication can improve the succes...
By PharmaVoice Team • Dec. 30, 2008
Previous
